You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 5, May 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Radiologic Imaging
 •Diagnosis
 •Magnetic Resonance Imaging
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis

Àlex Rovira, MD; Josephine Swanton, MD; Mar Tintoré, MD; Elena Huerga, RT; Fredrick Barkhof, MD; Massimo Filippi, MD; Jette L. Frederiksen, MD; Annika Langkilde, MD; Katherine Miszkiel, MD; Chris Polman, MD; Marco Rovaris, MD; Jaume Sastre-Garriga, MD; David Miller, MD; Xavier Montalban, MD

Arch Neurol. 2009;66(5):587-592.

Background  A diagnosis of multiple sclerosis in patients who present for the first time with a clinically isolated syndrome (CIS) can be established with brain magnetic resonance imaging (MRI) if the MRI demonstrates demyelinating lesions with dissemination in space (DIS) and dissemination in time (DIT).

Objective  To investigate the diagnostic performance of a single MRI study obtained within the first 3 months after symptom onset in a cohort of patients with a CIS suggestive of multiple sclerosis at presentation.

Design  Multicenter inception cohort with a follow-up of at least 24 months.

Setting  Referral hospitals.

Patients  Patients with CIS onset between April 1, 1995, and September 30, 2004, who fulfilled the following criteria were included: (1) age of 14 to 50 years and (2) clinical follow-up for at least 24 months after CIS onset or until development of clinically definite multiple sclerosis (CDMS), if this occurred within 2 years.

Main Outcome Measure  All patients underwent 2 comparable brain MRI examinations, the first within 3 months (early) and the second between 3 and 12 months (delayed) after CIS onset. We defined DIS using several existing MRI criteria, and DIT was inferred when there were simultaneous gadolinium-enhancing and nonenhancing lesions on a single MRI.

Results  Two hundred fifty patients were included in the study. The comparison of the diagnostic performance of various MRI criteria for identifying early converters to CDMS showed similar sensitivity and specificity between early and delayed MRIs. In addition, the use of less stringent criteria for DIS yielded better sensitivity and similar specificity, particularly when assessed in the first weeks after CIS onset.

Conclusion  A single brain MRI study that demonstrates DIS and shows both gadolinium-enhancing and nonenhancing lesions that suggest DIT is highly specific for predicting the early development of CDMS, even when the MRI is performed within the first 3 months after the onset of a CIS.


Author Affiliations: Magnetic Resonance Unit, Department of Radiology, and Neuroimmunology Unit, CEM-CAT, Hospital Vall d’Hebron, Autonomous University of Barcelona, Barcelona, Spain (Drs Rovira, Tintoré, Sastre-Garriga, and Montalban and Ms Huerga); Multiple Sclerosis Nuclear Magnetic Resonance Research Unit, Department of Neuroinflammation, Institute of Neurology, University College London (Drs Swanton and Miller), and Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, England (Dr Miszkiel); Department of Neuroradiology and Neurology, Vrije Universiteit University Medical Centre, Amsterdam, the Netherlands (Drs Barkhof and Polman); Neuroimaging Research Unit, Department of Neurology, San Raffaele Scientific Institute and University (Dr Filippi), and Multiple Sclerosis Centre, Scientific Institute Santa Maria Nascente, Fondazione Don Gnocchi (Dr Rovaris), Milan, Italy; and Department of Neurology and MRI Research Unit, Glostrup University Hospital, Copenhagen, Denmark (Drs Frederiksen and Langkilde).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(5):552-553.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.